Even before the new US President has been inaugurated, the health care provision introduced to ensure affordable health care for millions of poorer Americans – and heavily criticized by Donald Trump during his election campaign – appears to be on its way out.
It follows a vote late on Wednesday which saw 51 Senators to 48 voting to pass a budget which instructs committees to write measures ending large parts of the Affordable Care Act (ACA). This health insurance scheme is often called ‘Obamacare,’ having been one of the pillars of Barack Obama’s domestic policy.
Protests by Democratic Senators at the potential impact on as many as 20 million Americans who have been insured by the ACA were ignored as the budget was approved, an action which, the New York Times explains, sets the stage for a reconciliation bill that can then be used to repeal significant parts of the health law and, critically, is immune from being blocked.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze